Akèy › Sarkom tisi mou › Alabama › Birmingham
Etid klinik pou Sarkom tisi mou nan Birmingham, AL
5 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
- Research Site, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Ap rekriteFaz 2
- Children's of Alabama, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
- University of Alabama at Birmingham, Birmingham
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Ap rekriteFaz 2
- Children's Hospital of Alabama/UAB, Birmingham
Etid Sarkom tisi mou nan lòt vil
- Houston, TX33 etid
- New York City, NY20 etid
- Boston, MA18 etid
- St. Louis, MO14 etid
- Los Angeles, CA13 etid
- Columbus, OH13 etid
- Washington, DC12 etid
- Memphis, TN11 etid
- Philadelphia, PA10 etid
- Nashville, TN9 etid
- Rochester, MN9 etid
- Queens, NY9 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Kansè ovè23 etid
- Obèsite23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Dyabèt Tip 216 etid
- Sipwa16 etid
- Fibroz sistik16 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.